These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15833992)

  • 41. Imaging Characteristics of Liver Metastases Overlooked at Contrast-Enhanced CT.
    Nakai H; Arizono S; Isoda H; Togashi K
    AJR Am J Roentgenol; 2019 Apr; 212(4):782-787. PubMed ID: 30779660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?
    Sheafor DH; Killius JS; Paulson EK; DeLong DM; Foti AM; Nelson RC
    Radiology; 2000 Mar; 214(3):875-80. PubMed ID: 10715061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.
    O'Neill AC; Somarouthu B; Tirumani SH; Braschi-Amirfarzan M; Van den Abbeele AD; Ramaiya NH; Shinagare AB
    Radiology; 2017 Jan; 282(1):160-170. PubMed ID: 27479640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging features of perivascular fatty infiltration of the liver: initial observations.
    Hamer OW; Aguirre DA; Casola G; Sirlin CB
    Radiology; 2005 Oct; 237(1):159-69. PubMed ID: 16100085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging.
    Ward J; Robinson PJ; Guthrie JA; Downing S; Wilson D; Lodge JP; Prasad KR; Toogood GJ; Wyatt JI
    Radiology; 2005 Oct; 237(1):170-80. PubMed ID: 16126930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
    Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Macapinlac HA
    Radiology; 2008 Apr; 247(1):189-96. PubMed ID: 18372468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sonography of the liver following CT staging of patients with lung cancer: a retrospective analysis].
    Prosch H; Oschatz E; Eisenhuber E; Gahleitner S; Hochmair M; Mashaal S; Mostbeck GH
    Ultraschall Med; 2009 Dec; 30(6):551-7. PubMed ID: 19809967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.
    Zacharia TT; Saini S; Halpern EF; Sumner JE
    AJR Am J Roentgenol; 2006 Apr; 186(4):1067-70. PubMed ID: 16554580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.
    Utsunomiya D; Shiraishi S; Imuta M; Tomiguchi S; Kawanaka K; Morishita S; Awai K; Yamashita Y
    Radiology; 2006 Jan; 238(1):264-71. PubMed ID: 16304081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency and clinical significance of previously undetected incidental findings detected on computed tomography simulation scans for breast cancer patients.
    Nakamura N; Tsunoda H; Takahashi O; Kikuchi M; Honda S; Shikama N; Akahane K; Sekiguchi K
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):602-5. PubMed ID: 22436792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
    Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
    Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer.
    Eberhardt SC; Choi PH; Bach AM; Funt SA; Felderman HE; Hann LE
    J Ultrasound Med; 2003 Apr; 22(4):335-43; quiz 345-6. PubMed ID: 12693617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better?
    Haider MA; Amitai MM; Rappaport DC; O'Malley ME; Hanbidge AE; Redston M; Lockwood GA; Gallinger S
    Radiology; 2002 Oct; 225(1):137-42. PubMed ID: 12354997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT.
    Harned RK; Chezmar JL; Nelson RC
    AJR Am J Roentgenol; 1994 Jul; 163(1):93-7. PubMed ID: 8010256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of bone metastases: assessment of integrated FDG PET/CT imaging.
    Taira AV; Herfkens RJ; Gambhir SS; Quon A
    Radiology; 2007 Apr; 243(1):204-11. PubMed ID: 17392254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cirrhosis or chronic hepatitis: evaluation of small (Shimizu A; Ito K; Koike S; Fujita T; Shimizu K; Matsunaga N
    Radiology; 2003 Feb; 226(2):550-5. PubMed ID: 12563153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history.
    Gladish GW; Choe DH; Marom EM; Sabloff BS; Broemeling LD; Munden RF
    Radiology; 2006 Jul; 240(1):246-55. PubMed ID: 16684921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.